Artículos por temáticas

Coffee consumption is associated with later age-at-onset of Parkinson's disease

Kuzovenkova D, Liu L, Gan-Or Z, Senkevich K.

medRxiv [Preprint]. 2025 Feb 10:2025.02.07.25321819. doi: 10.1101/2025.02.07.25321819.

Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers

Song J, Cho E, Lee H, Lee S, Kim S, Kim J.

Biosensors (Basel). 2025 Feb 11;15(2):102. doi: 10.3390/bios15020102.

Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

Meng K, Jia H, Hou X, Zhu Z, Lu Y, Feng Y, Feng J, Xia Y, Tan R, Cui F, Yuan J.

Biomedicines. 2025 Jan 31;13(2):327. doi: 10.3390/biomedicines13020327.

Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium

Elyaman W, Stern LJ, Jiang N, Dressman D, Bradley P, Klatzmann D, Bradshaw EM, Farber DL, Kent SC, Chizari S, Funk K, Devanand D, Thakur KT, Raj T, Dalahmah OA, Sarkis RA, Weiner HL, Shneider NA, Prze

Alzheimers Dement. 2025 Feb;21(2):e14548. doi: 10.1002/alz.14548. Epub 2025 Jan 27.

Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders

Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, Singh G, Iqbal D, Padmapriya G, Kumar S, Kedia N, Verma R, Kumar R, Sinha A, Dheepak B, Abomughaid MM, Jha NK.

Mol Neurobiol. 2025 Feb 17. doi: 10.1007/s12035-024-04654-y. Online ahead of print.

The roles of functional bacterial amyloids in neurological physiology and pathophysiology: Pros and cons for neurodegeneration

Halimi H, Ahmadi B, Asri N, Rostami-Nejad M, Houri H.

Microb Pathog. 2025 Mar;200:107363. doi: 10.1016/j.micpath.2025.107363. Epub 2025 Feb 3.

[Functional disorders of the lower urinary tract: Parkinson's disease]

Knüpfer SC.

Urologie. 2025 Feb;64(2):120-127. doi: 10.1007/s00120-024-02508-y. Epub 2025 Feb 3.

The 6-OHDA Parkinson's Disease Mouse Model Shows Deficits in Sensory Behavior

Linen SR, Chang NH, Hess EJ, Stanley GB, Waiblinger C.

bioRxiv [Preprint]. 2025 Jan 29:2024.06.05.597339. doi: 10.1101/2024.06.05.597339.

A novel alpha-synuclein K58N missense variant in a patient with Parkinson's disease

Al-Azzani M, Weber S, Ramalingam N, Ramón M, Shvachiy L, Mestre G, Zech M, Sicking K, Ibáñez de Opakua A, Jayanthi V, Amaral L, Agarwal A, Chandran A, Chaves SR, Winkelmann J, Trenkwalder C, Schwager

medRxiv [Preprint]. 2025 Feb 14:2025.02.07.25321793. doi: 10.1101/2025.02.07.25321793.

"Extracellular Vesicle DNA: Advances and Applications as a Non-Invasive Biomarker in Disease Diagnosis and Treatment"

Shinde U, Balasinor NH, Ravichandran V, Kumar AS, Gunasekaran VP.

Clin Chim Acta. 2025 Feb 15;568:120125. doi: 10.1016/j.cca.2025.120125. Epub 2025 Jan 8.

Effect of power training on physical functional performance of patients with Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials

de Almeida SB, Tavares Sobreira ES, de Lucena Alves CP, Lima DP, de Carvalho Bonfadini J, Sobreira-Neto MA, Freitas TH, do Nascimento SL, Braga-Neto P.

PLoS One. 2025 Feb 4;20(2):e0314058. doi: 10.1371/journal.pone.0314058. eCollection 2025.

Acute Neuropsychiatric Decline in a Parkinson's Disease Patient with a Severe GBA1 Mutation Following Bilateral GPi Deep Brain Stimulation

Palakuzhy VG, Pal GD, Afshari M.

Mov Disord Clin Pract. 2025 Feb 24. doi: 10.1002/mdc3.70015. Online ahead of print.

The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms

Savulescu-Fiedler I, Dorobantu-Lungu LR, Dragosloveanu S, Benea SN, Dragosloveanu CDM, Caruntu A, Scheau AE, Caruntu C, Scheau C.

Curr Issues Mol Biol. 2025 Feb 11;47(2):115. doi: 10.3390/cimb47020115.

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials

Hakami AY, Alshehri FS.

Front Pharmacol. 2025 Feb 6;16:1521792. doi: 10.3389/fphar.2025.1521792. eCollection 2025.

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors

Bindra S, Mostafa EM, Abdelgawad MA, Selim S, Kumar S, Mathew B.

RSC Med Chem. 2025 Feb 6. doi: 10.1039/d4md00837e. Online ahead of print.